New York State Common Retirement Fund Ultragenyx Pharmaceutical Inc. Transaction History
New York State Common Retirement Fund
- $74.6 Billion
- Q4 2024
A detailed history of New York State Common Retirement Fund transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 58,571 shares of RARE stock, worth $2.32 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
58,571
Previous 63,571
7.87%
Holding current value
$2.32 Million
Previous $3.53 Million
30.22%
% of portfolio
0.0%
Previous 0.0%
Shares
30 transactions
Others Institutions Holding RARE
# of Institutions
345Shares Held
86.7MCall Options Held
675KPut Options Held
846K-
Vanguard Group Inc Valley Forge, PA10MShares$398 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$222 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA4.3MShares$171 Million0.57% of portfolio
-
State Street Corp Boston, MA2.72MShares$108 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.51MShares$99.7 Million0.01% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $2.78B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...